Lotensin Hct
Product Images NDC 54868-5313

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lotensin Hct (NDC 54868-5313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel – Package Label – 20 mg/12.5 mg Tablets. (4904)

Principal Display Panel – Package Label – 20 mg/12.5 mg Tablets. (4904)
FDA Label Image

Principal Display Panel – Package Label – 20 mg/25 mg Tablets. (5313)

Principal Display Panel – Package Label – 20 mg/25 mg Tablets. (5313)
FDA Label Image

Benazepril Hydrochloride Structural Formula. (Lotensin Hct 02)

Benazepril Hydrochloride Structural Formula. (Lotensin Hct 02)
FDA Label Image

Hydrochlorothiazide Structural Formula. (Lotensin Hct 03)

Hydrochlorothiazide Structural Formula. (Lotensin Hct 03)